http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#Head
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#assertion
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#provenance
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#pubinfo
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#assertion
http://purl.obolibrary.org/obo/DOID_7148
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_7148
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00482
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
http://www.w3.org/2000/01/rdf-schema#label
carefully consider the potential benefits and risks of celebrex and other treatment options before deciding to use celebrex use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings and precautions 5 celebrex is a nonsteroidal anti inflammatory drug indicated for osteoarthritis oa 1 1 rheumatoid arthritis ra 1 2 juvenile rheumatoid arthritis jra in patients 2 years and older 1 3 ankylosing spondylitis as 1 4 acute pain ap 1 5 primary dysmenorrhea pd 1 6 familial adenomatous polyposis fap adjunct to usual care 1 7 celebrex is indicated for relief of the signs and symptoms of oa see clinical studies 14 1 celebrex is indicated for relief of the signs and symptoms of ra see clinical studies 14 2 celebrex is indicated for relief of the signs and symptoms of jra in patients 2 years and older see clinical studies 14 3 celebrex is indicated for the relief of signs and symptoms of as see clinical studies 14 4 celebrex is indicated for the management of ap in adults see clinical studies 14 5 celebrex is indicated for the treatment of pd see clinical studies 14 5 celebrex is indicated to reduce the number of adenomatous colorectal polyps in fap as an adjunct to usual care e g endoscopic surveillance surgery it is not known whether there is a clinical benefit from a reduction in the number of colorectal polyps in fap patients it is also not known whether the effects of celebrex treatment will persist after celebrex is discontinued the efficacy and safety of celebrex treatment in patients with fap beyond six months have not been studied see warnings and precautions 5 15 clinical studies 14 6
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB00482
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#provenance
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#pubinfo
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig
http://purl.org/nanopub/x/hasSignature
Q+JKR+KWu+q1TZJIbH4wJBB0eB57khi3w4xbAZ7BNwbgTROfp1FtUe4c3c8lJ4DuDVPF+2tBkm7EDbYn3MdVk77ymK9I32iHIFf8xgSNrNOIkkljujXDjdrFA0dqDMkYUSK0GF80q/YD/QK6Klm4l4VU32WA12wAGWsGjxITkxk=
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://purl.org/dc/terms/created
2021-06-29T08:54:30.583+02:00
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs